SAKAR HEALTHCARE
|
The Current P/S Ratio of SAKAR HEALTHCARE is 5.29.
| Share Price | ₹599.5 | May 13,2026 |
| Market Cap | ₹1,330.8 Cr | |
| Sales-TTM | ₹251.7 Cr | TTM-Consolidated Results |
| Price/Sales | 5.29x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SAKAR HEALTHCARE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,330.8 Cr] as on May 13,2026
(/) Sales [ ₹251.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.29x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay '5.29 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SAKAR HEALTHCARE !
The chart below summarizes the trend in P/S Ratio of SAKAR HEALTHCARE over the last five years.
Historical PS (Price/Sales) ratio chart of SAKAR HEALTHCARE
PS Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.87x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 2.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 5.22x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2022 of 1.8x.
How does SAKAR HEALTHCARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SAKAR HEALTHCARE | 251.7 | 5.29 | 1,330.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.71 | 437,735.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 17.48 | 180,312.0 |
| CIPLA LTD | 28,162.6 | 3.81 | 107,205.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.41 | 145,369.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.13 | 105,592.0 |
| MANKIND PHARMA LTD | 13,914.1 | 7.14 | 99,384.3 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.62 | 94,480.3 |
| LUPIN LTD | 27,958.0 | 3.62 | 101,294.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.62 | 86,978.0 |
| ABBOTT INDIA LTD | 6,929.1 | 8.36 | 57,928.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAKAR HEALTHCARE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.62x |
| Max industry PS | 17.48x |
| Median industry PS | 5.29x |
| Average industry PS | 6.74x |
You may also like the below Video Courses